Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Bachtler, Barbara (1) Bader, Michael Prof. Dr. (20) Bähring, Sylvia Dr. (2) Birchmeier, Walter Prof. Dr. (7) Birchmeier-Kohler, Carmen Prof. Dr. (9) Dechend, Ralf Priv. Doz. (6) Falcke, Martin Prof. Dr. (4) Fielitz, Jens Dr. (1) Gerhardt, Holger Prof. Dr. (6) Gotthardt, Michael Prof. Dr. (4) Heinemann, Udo Prof. Dr. (3) Ivics, Zoltan Dr. (2) Izsvak, Zsuzsanna Dr. (2) Jentsch, Thomas Prof. Dr. (14) Kammertöns, Thomas Dr. (3) Kempa, Stefan Dr. (1) Kettenmann, Helmut Prof. Dr. (8) Kettritz, Ralph Prof. Dr. (5) Klußmann, Enno PD Dr. (1) Lee, Young-Ae Prof. Dr. (5) Leutz, Achim Prof. Dr. (1) Lewin, Gary Prof. Dr. (3) Luft, Friedrich Prof. Dr. (52) Mathas, Stephan Dr. (1) Morano, Ingo Prof. Dr. (5) Niendorf, Thoralf Prof. Dr. (1) Ohler, Uwe Prof. Dr. (3) Pezzutto, Antonio Prof. Dr. (3) Pischon, Tobias Prof. Dr. (2) Rahn, Hans-Peter Dr. (1) Rajewsky, Nikolaus Prof. Dr. (2) Rehm, Armin Dr. (1) Saar, Kathrin Dr. (1) Sander, Maike Prof. Dr. (2) Scheidereit, Claus Prof. Dr. (6) Schlag, Peter M. Prof. Dr. (8) Schulz-Menger, Jeanette Prof. Dr. (5) Sporbert, Anje Dr. (2) Stein, Ulrike Prof. Dr. (8) von Kries, Jens Peter Dr. (1) Waiczies, Sonia PD Dr. (1) Wallukat, Gerd Dr. (2) Walther, Wolfgang Prof. Dr. (7) Wanker, Erich Prof. Dr. (5) Willimsky, Gerald Dr. (3) Willnow, Thomas Prof. Dr. (4) Wolf, Jana Prof. Dr. (2) (-) Blankenstein, Thomas Prof. Dr. (8) (-) Müller, Dominik Prof. Dr. (6) AG Müller/Dechend (ECRC) (6) Hypertonie-vermittelter Endorganschaden (6) Hypertonie bedingte Endorganschäden (6) Molekularbiologie von Hormonen im Herz-Kreislaufssystem (1) Molekulare Immunologie und Gentherapie (8) 1992 (4) 1993 (7) 1994 (5) 1995 (9) 1996 (6) 1997 (10) 1998 (12) 1999 (5) (-) 2000 (14) 2001 (18) 2004 (17) 2005 (22) 2006 (8) 2007 (21) 2008 (23) 2009 (19) 2010 (29) 2011 (24) 2012 (23) 2013 (28) 2014 (18) 2015 (17) 2016 (25) 2017 (23) 2018 (18) 2019 (30) 2020 (23) 2021 (24) 2022 (21) 2023 (18) 2024 (5) 14 Ergebnisse: Active Filter: Blankenstein, Thomas Prof. Dr.Müller, Dominik Prof. Dr.2000 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 01. Januar 2000 / Hypertension NF-kappaB Inhibition Ameliorates Angiotensin II-Induced Inflammatory Damage in Rats D.N. Muller R. Dechend E.M.A. Mervaala J.K. Park F. Schmidt A. Fiebeler J. Theuer V. Breu D. Ganten H. Haller F.C. Luft 01. Januar 2000 / Hypertension Cyclosporin A protects against angiotensin II-induced end-organ damage in double transgenic rats harboring human renin and angiotensinogen genes E. Mervaala D.N. Mueller J.K. Park R. Dechend F. Schmidt A. Fiebeler M. Bieringer V. Breu D. Ganten H. Haller F.C. Luft 01. Februar 2000 / Canc Res Interleukin-7/B7.1-encoding adenoviruses induce rejection of transplanted but not nontransplanted tumors G. Willimsky T. Blankenstein 01. Februar 2000 / Hypertension Blood pressure-independent effects in rats with human renin and angiotensinogen genes E. Mervaala D.N. Mueller F. Schmidt J.K. Park V. Gross M. Bader V. Breu D. Ganten H. Haller F.C. Luft 01. Januar 2000 / Hum Gene Ther Efficient gene transfer into primary human CD8+ T lymphocytes by MuLV-10A1 retrovirus pseudotype W. Uckert C. Becker M. Gladow D. Klein T. Kammertoens L. Pedersen T. Blankenstein 01. Juni 2000 / Immunity CD4+ T cell-mediated tumor rejection involves inhibition of angiogenesis that is dependent on IFNgamma receptor expression by nonhematopoietic cells Z.H. Qin T. Blankenstein 01. Mai 2000 / Bone Marrow Transplant Bcr/abl+ autologous dendritic cells for vaccination in chronic myeloid leukemia J. Westermann J. Kopp I. Koerner G. Richter Z. Qin T. Blankenstein B. Doerken A. Pezzutto 01. Mai 2000 / Bone Marrow Transplant Allogeneic vaccination for renal cell carcinoma: development and monitoring H. Pohla B. Frankenberger B. Stadlbauer R. Oberneder A. Hofstetter G. Willimsky A. Pezzutto B. Doerken T. Blankenstein D.J. Schendel 01. Juli 2000 / Am J Pathol Angiotensin II (AT1) receptor blockade reduces vascular tissue factor in angiotensin II-induced cardiac vasculopathy D.N. Mueller E.M.A. Mervaala R. Dechend A. Fiebeler J.K. Park F. Schmidt J. Theuer V. Breu N. Mackman T. Luther W. Schneider D. Gulba D. Ganten H. Haller F.C. Luft 01. August 2000 / Hypertension Effect of Bosentan on NF-kappaB, inflammation, and tissue factor in angiotensin II-induced end-organ damage D.N. Muller E.M.A. Mervaala F. Schmidt J.K. Park R. Dechend E. Genersch V. Breu B.M. Loeffler D. Ganten W. Schneider H. Haller F.C. Luft Seitennummerierung Aktuelle Seite 1 Seite 2 Nächste Seite Next › Letzte Seite Last »
01. Januar 2000 / Hypertension NF-kappaB Inhibition Ameliorates Angiotensin II-Induced Inflammatory Damage in Rats D.N. Muller R. Dechend E.M.A. Mervaala J.K. Park F. Schmidt A. Fiebeler J. Theuer V. Breu D. Ganten H. Haller F.C. Luft
01. Januar 2000 / Hypertension Cyclosporin A protects against angiotensin II-induced end-organ damage in double transgenic rats harboring human renin and angiotensinogen genes E. Mervaala D.N. Mueller J.K. Park R. Dechend F. Schmidt A. Fiebeler M. Bieringer V. Breu D. Ganten H. Haller F.C. Luft
01. Februar 2000 / Canc Res Interleukin-7/B7.1-encoding adenoviruses induce rejection of transplanted but not nontransplanted tumors G. Willimsky T. Blankenstein
01. Februar 2000 / Hypertension Blood pressure-independent effects in rats with human renin and angiotensinogen genes E. Mervaala D.N. Mueller F. Schmidt J.K. Park V. Gross M. Bader V. Breu D. Ganten H. Haller F.C. Luft
01. Januar 2000 / Hum Gene Ther Efficient gene transfer into primary human CD8+ T lymphocytes by MuLV-10A1 retrovirus pseudotype W. Uckert C. Becker M. Gladow D. Klein T. Kammertoens L. Pedersen T. Blankenstein
01. Juni 2000 / Immunity CD4+ T cell-mediated tumor rejection involves inhibition of angiogenesis that is dependent on IFNgamma receptor expression by nonhematopoietic cells Z.H. Qin T. Blankenstein
01. Mai 2000 / Bone Marrow Transplant Bcr/abl+ autologous dendritic cells for vaccination in chronic myeloid leukemia J. Westermann J. Kopp I. Koerner G. Richter Z. Qin T. Blankenstein B. Doerken A. Pezzutto
01. Mai 2000 / Bone Marrow Transplant Allogeneic vaccination for renal cell carcinoma: development and monitoring H. Pohla B. Frankenberger B. Stadlbauer R. Oberneder A. Hofstetter G. Willimsky A. Pezzutto B. Doerken T. Blankenstein D.J. Schendel
01. Juli 2000 / Am J Pathol Angiotensin II (AT1) receptor blockade reduces vascular tissue factor in angiotensin II-induced cardiac vasculopathy D.N. Mueller E.M.A. Mervaala R. Dechend A. Fiebeler J.K. Park F. Schmidt J. Theuer V. Breu N. Mackman T. Luther W. Schneider D. Gulba D. Ganten H. Haller F.C. Luft
01. August 2000 / Hypertension Effect of Bosentan on NF-kappaB, inflammation, and tissue factor in angiotensin II-induced end-organ damage D.N. Muller E.M.A. Mervaala F. Schmidt J.K. Park R. Dechend E. Genersch V. Breu B.M. Loeffler D. Ganten W. Schneider H. Haller F.C. Luft